Medisorb naltrexone 380 mg

DRUG6 trials

Sponsors

Alkermes, Inc.

Conditions

Alcohol DependenceAlcoholismOpiate Dependence

Phase 3

ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997])

TerminatedNCT00156936

Alkermes, Inc.Alcoholism, Opiate Dependence

Start: 2004-08-31End: 2007-01-31Updated: 2010-11-17

ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent Adults

CompletedNCT00156923

Alkermes, Inc.Alcoholism

Start: 2003-10-31End: 2007-01-31Updated: 2017-07-11

ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care Professionals

CompletedNCT00834080

Alkermes, Inc.Opiate Dependence

Start: 2009-03-31End: 2012-05-31Updated: 2018-12-11

ALK21-003: Study of Medisorb® Naltrexone (VIVITROL®) in Alcohol-Dependent Adults

CompletedNCT01218958

Alkermes, Inc.Alcoholism

Start: 2002-02-28End: 2003-09-30Updated: 2017-07-11

ALK21-006: Long-Term Study of Medisorb® Naltrexone (VIVITROL®)

CompletedNCT01218997

Alkermes, Inc.Alcoholism

Start: 2003-08-31End: 2005-03-31Updated: 2011-01-04

ALK21-003EXT: An Extension of Study ALK21-003 (NCT01218958) to Test the Long-term Safety of Medisorb® Naltrexone (VIVITROL®)

CompletedNCT01218971

Alkermes, Inc.Alcohol Dependence

Start: 2002-08-31End: 2004-09-30Updated: 2010-12-24